Moist powder tobacco “snus” cans are seen on shelves at a Swedish Match store in Stockholm, Sweden October 24, 2018. Picture taken October 24, 2018. REUTERS/Anna Ringstrom/File PhotoRegister now for FREE unlimited access to Reuters.comReporting by Richa Naidu; editing by David Evans and Emelia Sithole-MatariseOur Standards: The Thomson Reuters Trust Principles. .
LONDON, May 12 (Reuters) – Philip Morris’ $16 billion offer for Stockholm-based Swedish Match (SWMA.ST) represents a “healthy premium” and the Marlboro maker could yet go higher, Swedish Match’s No. 10 shareholder GACMO Investors (GBL.N) said on Thursday.Marlboro maker Philip Morris agreed on Wednesday to buy Swedish Match, one of the world’s biggest makers of oral nicotine products. These include Snus – a sucked tobacco product the firm says is less harmful than smoking – as well as Zyn nicotine pouches, which are used the same way and tobacco-free.Kevin Dreyer, co-chief investment officer, value, at GAMCO identified Japan Tobacco Inc (2914.T) (JTI) as a possible rival bidder but said it would be hard-pressed to hijack the deal. GAMCO, formerly known as Gabelli Asset Management Company, owns just over 2% of Swedish Match, according to Refinitiv.Register now for FREE unlimited access to Reuters.com “PMI has very deep pockets and will be a tough company to out-bid,” he said. “This deal is really the culmination of the last five-to-seven years of work Swedish Match has done in developing Zyn into the leading brand, and having that advantageous market share – it’s an attractive stock.”Philip Morris declined to comment. Swedish Match and JTI did not immediately respond to a request for comment.Philip Morris needs at least 90% of shareholders to approve the deal for it to succeed. Some other shareholders have questioned whether the Philip Morris offer represents good value. Swedish Match shareholder Bronte Capital said on Wednesday the price Philip Morris agreed to pay was “unacceptable”.Register now for FREE unlimited access to Reuters.comTwitter set to accept Musk’s $43 billion offer
Elon Musk’s twitter account is seen through the Twitter logo in this illustration taken, April 25, 2022. REUTERS/Dado Ruvic/Illustration Register now for FREE unlimited access to Reuters.comReporting by Greg Roumeliotis in New York, additional reporting by Krystal Hu;
Editing by Mark PotterOur Standards: The Thomson Reuters Trust Principles. .
Analysis: Positive real yields may spell more trouble for U.S. stocks
A street sign for Wall Street is seen in the financial district in New York, U.S., November 8, 2021. REUTERS/Brendan McDermid/File Photo/File PhotoRegister now for FREE unlimited access to Reuters.comReuters GraphicsOn Tuesday, stocks shrugged off the rise in yields, with the S&P 500 ending up 1.6% on the day. Still, the S&P 500 is down 6.4% this year, while the yield on the 10-year TIPS has climbed more than 100 basis points.”Real 10-year yields are the risk-free alternative to owning stocks,” said Barry Bannister, chief equity strategist at Stifel. “As real yield rises, at the margin it makes stocks less attractive.”One key factor influenced by yields is the equity risk premium, which measures how much investors expect to be compensated for owning stocks over government bonds.Rising yields have helped result in the measure standing at its lowest level since 2010, Truist Advisory Services said in a note last week.
Reuters GraphicsHEADWIND TO GROWTH SHARESHigher yields in particular dull the allure of companies in technology and other high-growth sectors, with those companies’ cash flows often more weighted in the future and diminished when discounted at higher rates.That may be bad news for the broader market. The heavy presence of tech and other growth stocks in the S&P 500 means the index’s overall expected dividends are weighted in the future at close to their highest level ever, according to BofA Global Research. Five massive, high-growth stocks, for example, now make up 22% of the weight of the S&P 500.At the same time, growth shares in recent years have been highly linked to the movement of real yields.Since 2018, a ratio comparing the performance of the Russell 1000 growth index (.RLG) to its counterpart for value stocks (.RLV) – whose cash flows are more near-term – has had a negative 96% correlation with 10-year real rates, meaning they tend to move in opposite directions from growth stocks, according to Ohsung Kwon, a U.S. equity strategist at BofA Global Research.Rising yields are “a bigger headwind to equities than (they have) been in history,” he said.
Top five stocks market cap as percentage of S&P 500Bannister estimates the S&P 500 could retest its lows of the year, which included a drop in March of 13% from the index’s record high, should the yield on the 10-year TIPS rise to 0.75% and the earnings outlook – a key component of the risk premium – remain unchanged.Lofty valuations also make stocks vulnerable if yields continue rising. Though the tumble in stocks has moderated valuations this year, the S&P 500 still trades at about 19 times forward earnings estimates, compared with a long-term average of 15.5, according to Refinitiv Datastream.“Valuations aren’t great on stocks right now. That means that capital may look at other alternatives to stocks as they become more competitive,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.Still, some investors believe stocks can survive just fine with rising real yields, for now. Real yields were mostly in positive territory over the past decade and ranged as high as 1.17% while the S&P 500 has climbed over 200%.JPMorgan strategists earlier this month estimated that equities could cope with 200 basis points of real yield increases. They advised clients maintain a large equity versus bond overweight.”If bond yield rises continue, they could eventually become a problem for equities,” the bank’s strategists said. “But we believe current real bond yields at around zero are not high enough to materially challenge equities.”Register now for FREE unlimited access to Reuters.comReporting by Lewis Krauskopf in New York
Editing by Ira Iosebashvili and Matthew LewisOur Standards: The Thomson Reuters Trust Principles. .
Ramsay Health Care gets $14.8 bln bid from KKR-led consortium; shares soar
Trading information for KKR & Co is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., August 23, 2018. REUTERS/Brendan McDermidRegister now for FREE unlimited access to Reuters.com
- Ramsay receives A$88 cash per share proposal
- Proposal at a 37% premium to Ramsay’s last close
- Ramsay stock up 29.8% in early trade
April 20 (Reuters) – Ramsay Health Care Ltd (RHC.AX), Australia’s largest private hospital operator, said on Wednesday it received a A$20.05 billion ($14.80 billion) indicative takeover offer from a consortium led by private equity giant KKR & Co (KKR.N).The non-binding proposal of A$88 cash per share represents a premium of nearly 37% to Ramsay’s Tuesday closing price of A$64.39. The offer sent the hospital operator’s shares up as much as 29.8% to A$83.55 in early trade, their biggest-ever intraday jump.Ramsay said in a statement it would provide the KKR-led consortium with due diligence on a non-exclusive basis and talks were at a preliminary stage.Register now for FREE unlimited access to Reuters.comReporting by Harish Sridharan in Bengaluru; additional reporting by Byron Kaye in Sydney; Editing by Sriraj Kalluvila, Aditya Soni and Krishna Chandra Eluri and Rashmi AichOur Standards: The Thomson Reuters Trust Principles. .
The hospital operator said it had reviewed the proposal with its advisers and asked for further information from the consortium in relation to its funding and structure of the deal.KKR did not immediately respond to a Reuters request for comment.If successful, the takeover would be the biggest in Australia this year and nearly double deal activity, which at a total value of $17.4 billion, suffered a 41.2% decline in the first quarter compared with a year earlier, according to Refinitiv data.The proposal comes as record-low interest rates prompt private equity firms, superannuation and pension funds with ample liquidity to invest in healthcare and infrastructure assets.The deal would also rank as the second biggest private-equity backed in deal in Australia, following a consortium’s A$31.6 billion ($23.35 billion) enterprise value deal for Sydney airport last year. read more The pandemic hit healthcare operators including Ramsay, with the shutdown of non-urgent surgeries, staffing shortages due to isolation regulations, and upward wage pressure weighing on earnings and hurting stocks, making the sector relatively affordable for a buyout, compared to a few years ago.Last year, Australian biopharmaceutical giant CSL Ltd (CSL.AX) said it would buy Swiss drugmaker Vifor Pharma AG (VIFN.S) for $11.7 billion. read more Ramsay operates hospitals and clinics across 10 countries in three continents, with a network of more than 530 locations, according to its website.It has 72 private hospitals and day surgery units in Australia, while it operates clinics and primary care units in about 350 locations across six countries in Europe.KKR currently owns French healthcare group Elsan.Earlier this year, Ramsay and Malaysia’s Sime Darby Holdings received a $1.35 billion buyout offer from IHH Healthcare Bhd (IHHH.KL) for their Asia joint venture. Ramsay said it was still pursuing this transaction. The hospital operator has hired UBS AG’s Australia Branch and Herbert Smith Freehills as financial and legal advisers, respectively, for the KKR-led consortium’s proposal.($1 = 1.3535 Australian dollars)Register now for FREE unlimited access to Reuters.comBenetton team working on premium of around 30% to buy out Atlantia – sources
The logo of infrastructure group Atlantia in Rome, Italy October 5, 2020. REUTERS/Guglielmo MangiapaneRegister now for FREE unlimited access to Reuters.comAtlantia’s share performanceEdizione and Blackstone want to delist Atlantia to shield it from the appetite of rival suitors, who approached the Benettons last month with a proposal to buy the group and hand over Atlantia’s motorway concessions to Perez.GIP, Brookfield and the Spanish tycoon are in a ‘wait and see’ mode after the Benetton family and Atlantia’s long-time investors CRT and GIC rebuffed their offer, sources have said.The takeover offer comes as Atlantia prepares to pocket 8 billion euros from the sale of the group’s Italian motorway unit, a deal aimed at ending a political dispute triggered by the 2018 collapse of a motorway bridge.It also puts the spotlight on Alessandro Benetton, 58, who was appointed chairman of Edizione earlier this year, tightening the family’s grip on its investments.After parting ways with its Autostrade per l’Italia, Atlantia will continue to run airports in Italy and France, motorways in Europe and Latin America and digital toll payment company Telepass.The Italian government so far has been silent on the latest developments, but it has special vetting ‘golden’ powers over strategic assets, such as the country’s airports and their ownership.($1 = 0.9184 euro)Register now for FREE unlimited access to Reuters.comReporting by Francesca Landini and Stephen Jewkes
Editing by Mark Potter and Chizu NomiyamaOur Standards: The Thomson Reuters Trust Principles. .